Jul. 18 Pre-market Movers Board: Biophytis soars 60% premarket as the Co. to produce VIO101 active compound

Seize the market opportunities with us at 8:45 every morning, and don't forget to check our ‘Lunchtime Movers Board’ at 12:00.

Premarket Gainers: Biophytis, Aridis, Karyopharm, Zai Lab , Novartis

BPTS:

Biophytis soars 60% premarket after entering partnership with SEQENS to produce VIO101 active compound.

ARDS:

Aridis Pharmaceuticals surges 39% premarket after reaching agreement for phase 3 study of Pneumonia treatment in Europe.

KPTI:

Karyopharm Theraoeutics climbs 20% after securing FDA fast track designation for Selinexor for treatment of Myelofibrosis.

ZLAB:

Zai Lab spikes 6% premarket after reporting positive results in ADHERE study.

NVS:

Novartis shares up 3% premarket after Q2 sales were 3% above consensus.

Premarket Losers: Masimo, Cel-Sci, ProMIS, Novan, IronNet

MASI:

Masimo slumps 28% premarket after planning to lower 2023 revenue guidance.

CVM:

Cel-Sci tumbles 19% premarket after pricing $5M common stock offering.

PMN:

ProMIS Neurosciences drops 18% after exploding 120% at previous close.

NOVN: 

Novan sinks 11% premarket following its decline of 70% last close; The Co filed Chapter 11 Bankruptcy recently.

IRNT:

IronNet slides 5% premarket after intending to voluntarily delist securities from NYSE.

$BPTS(BPTS)$ARDS(ARDS)$KPTI(KPTI)$ZLAB(ZLAB)$NVS(NVS)$MASI(MASI)$CVM(CVM)$PMN(PMN)$NOVN(NOVN)$IRNT(IRNT)